These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Anticholinergic use in children and adolescents after initiation of antipsychotic therapy. Hong IS; Bishop JR Ann Pharmacother; 2010; 44(7-8):1171-80. PubMed ID: 20587746 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics. Miller CH; Mohr F; Umbricht D; Woerner M; Fleischhacker WW; Lieberman JA J Clin Psychiatry; 1998 Feb; 59(2):69-75. PubMed ID: 9501888 [TBL] [Abstract][Full Text] [Related]
7. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M; Shirakawa K; Matsuoka N; Mutoh S Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [TBL] [Abstract][Full Text] [Related]
8. Predictors for starting depot administration of risperidone in chronic users of antipsychotics. Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430 [TBL] [Abstract][Full Text] [Related]
9. Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control study. Schillevoort I; Herings RM; Hugenholtz GW; de Boer A; Nolen WA; Roos RA; Leufkens HG Pharm World Sci; 2005 Aug; 27(4):285-9. PubMed ID: 16228625 [TBL] [Abstract][Full Text] [Related]
10. A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database. Fleischhacker WW; Lemmens P; van Baelen B Pharmacopsychiatry; 2001 May; 34(3):104-10. PubMed ID: 11434401 [TBL] [Abstract][Full Text] [Related]
11. Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia. Ren XS; Huang YH; Lee AF; Miller DR; Qian S; Kazis L J Clin Pharm Ther; 2005 Feb; 30(1):65-71. PubMed ID: 15659005 [TBL] [Abstract][Full Text] [Related]
12. Movement Disorders in Children and Adolescents Receiving Antipsychotic Pharmacotherapy: A Population-Based Study. Biscontri RG; Jha S; Collins DM; Bugden S; Katz LY; Alessi-Severini S J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):892-896. PubMed ID: 29091743 [TBL] [Abstract][Full Text] [Related]
13. Rabbit syndrome secondary to risperidone. Hoy JS; Alexander B Pharmacotherapy; 2002 Apr; 22(4):513-5. PubMed ID: 11939686 [TBL] [Abstract][Full Text] [Related]
14. Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations? Schoretsanitis G; Haen E; Hiemke C; Gründer G; Stegmann B; Schruers KR; Veselinovic T; Lammertz SE; Paulzen M Int Clin Psychopharmacol; 2016 Sep; 31(5):259-64. PubMed ID: 27167902 [TBL] [Abstract][Full Text] [Related]
15. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Leucht S; Wahlbeck K; Hamann J; Kissling W Lancet; 2003 May; 361(9369):1581-9. PubMed ID: 12747876 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous and drug-induced movement disorders in schizophrenia. Kopala LC Acta Psychiatr Scand Suppl; 1996; 389():12-7. PubMed ID: 8985472 [TBL] [Abstract][Full Text] [Related]
17. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States. Feldman PD; Hay LK; Deberdt W; Kennedy JS; Hutchins DS; Hay DP; Hardy TA; Hoffmann VP; Hornbuckle K; Breier A J Am Med Dir Assoc; 2004; 5(1):38-46. PubMed ID: 14706127 [TBL] [Abstract][Full Text] [Related]
18. Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy. Carnahan RM; Lund BC; Perry PJ; Chrischilles EA Acta Psychiatr Scand; 2006 Feb; 113(2):135-41. PubMed ID: 16423165 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis. Bloechliger M; Rüegg S; Jick SS; Meier CR; Bodmer M CNS Drugs; 2015 Jul; 29(7):591-603. PubMed ID: 26242478 [TBL] [Abstract][Full Text] [Related]
20. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms. Timdahl K; Carlsson A; Stening G Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]